Back
 IJCM  Vol.7 No.10 , October 2016
Pharmacist and Physician Collaborative Practice Model Improves Vancomycin Dosing in an Intensive Care Unit
Abstract: Objective: A pharmacist and physician collaborative practice intervention to improve the initial dosing of vancomycin was implemented with the goal of decreasing the number of subtherapeutic first troughs and increasing the number of therapeutic troughs. Methods: Using the best available evidence, a nomogram was created to determine the initial vancomycin dose. The nomogram utilized actual bodyweight and glomerular filtration rate (eGFR) estimated with the MDRD4 equation. The dose was based on the 2009 ASHP/IDSA/SIDP guidelines, which recommended 15 - 20 mg/kg every 8 - 12 hours. Providers ordered “vancomycin IV dosed per pharmacy”. Results: The pre- (n = 75) and post-intervention (n = 108) cohorts had similar age, gender distribution, weight, and eGFR. The median total daily vancomycin dose was similar in pre- and post-intervention groups (2000 mg), although the median first trough was higher following the intervention (13.0 vs. 14.8 mcg/ml, p = 0.03). Following the intervention, the proportion of first troughs under 10 mcg/ml decreased (32% to 13%, p = 0.003), while the proportion of troughs in the 10 - 20 mcg/ml therapeutic range increased (50.7% vs. 69.4%, p = 0.01). There was no difference in the proportion of troughs over 20 mcg/ml (17.3% vs. 17.6%, p = 0.96). Conclusions: A multi-disciplinary intervention utilizing a nomogram-based pharmacy collaborative practice model significantly improves the proportion of therapeutic initial vancomycin troughs and decreases the number of subtherapeutic troughs by half.
Cite this paper: Levin, D. , Glasheen, J. and H. Kiser, T. (2016) Pharmacist and Physician Collaborative Practice Model Improves Vancomycin Dosing in an Intensive Care Unit. International Journal of Clinical Medicine, 7, 675-684. doi: 10.4236/ijcm.2016.710073.
References

[1]   Rybak, M., Lomaestro, B., Rotschafer, J.C., et al. (2009) Therapeutic Monitoring of Vancomycin in Adult Patients: A Consensus Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. American Society of Health System Pharmacists, 66, 82-98.
http://dx.doi.org/10.2146/ajhp080434

[2]   Karam, C.M., McKinnon, P.S., Neuhauser, M.M. and Rybak, M.J. (1999) Outcome Assessment of Minimizing Vancomycin Monitoring and Dosing Adjustments. Pharmacotherapy, 19, 257-266.
http://dx.doi.org/10.1592/phco.19.4.257.30933

[3]   Matzke, G.R., McGory, R.W., Halstenson, C.E. and Keane, W.F. (1984) Pharmacokinetics of Vancomycin in Patients with Various Degrees of Renal Function. Antimicrobial Agents and Chemotherapy, 25, 433-437.
http://dx.doi.org/10.1128/AAC.25.4.433

[4]   Niederman, M.S., Craven, D.E., Bonten, M.J., et al. (2005) Guidelines for the Management of Adults with Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia. American Journal of Respiratory and Critical Care Medicine, 171, 388-416.
http://dx.doi.org/10.1164/rccm.200405-644ST

[5]   Tunkel, A.R., Hartman, B.J., Kaplan, S.L., et al. (2004) Practice Guidelines for the Management of Bacterial Meningitis. Clinical Infectious Diseases, 39, 1267-1284.
http://dx.doi.org/10.1086/425368

[6]   Koshman, S.L., Charrois, T.L., Simpson, S.H., McAlister, F.A. and Tsuyuki, R.T. (2008) Pharmacist Care of Patients with Heart Failure. Archives of Internal Medicine, 168, 687-694. http://dx.doi.org/10.1001/archinte.168.7.687

[7]   Nkansah, N., Mostovetsky, O., Yu, C., et al. (2010) Effect of Outpatient Pharmacists’ Non-Dispensing Roles on Patient Outcomes and Prescribing Patterns. Cochrane Database of Systematic Reviews, 7, CD000336.
http://dx.doi.org/10.1002/14651858.cd000336.pub2

[8]   Makowsky, M.J., Koshman, S.L., Midodzi, W.K. and Tsuyuki, R.T. (2009) Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practicing in a Team Environment: The Collaborate Study. Medical Care, 47, 642-650.
http://dx.doi.org/10.1097/MLR.0b013e3181926032

[9]   Bearden, D.T. and Rodvold, K.A. (2000) Dosage Adjustments for Antibacterials in Obese Patients. Clinical Pharmacokinetics, 38, 415-426.
http://dx.doi.org/10.2165/00003088-200038050-00003

[10]   Bauer, L.A., Black, D.J. and Lill, J.S. (1998) Vancomycin Dosing in Morbidly Obese Patients. European Journal of Clinical Pharmacology, 54, 621-625.
http://dx.doi.org/10.1007/s002280050524

[11]   Levey, A.S., Coresh, J., Greene, T., et al. (2007) Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values. Clinical Chemistry, 53, 766-772.
http://dx.doi.org/10.1373/clinchem.2006.077180

[12]   Kitzis, M.D. and Goldstein, F.W. (2006) Monitoring of Vancomycin Serum Levels for the Treatment of Staphylococcal Infections. Clinical Microbiology and Infection, 12, 92-95.
http://dx.doi.org/10.1111/j.1469-0691.2005.01306.x

 
 
Top